Critical Care Equipment (CCE) Market Size, Share, Growth, and Industry Analysis, By Type (Patient Monitor,Medical Ventilator,Dialysis,IV Pumps,Infusion Pumps,Suction Apparatus,Others), By Application (Hospitals,Research laboratories,Others), Regional Insights and Forecast to 2035

Critical Care Equipment (CCE) Market Overview

The global Critical Care Equipment (CCE) Market is forecast to expand from USD 874.98 million in 2026 to USD 915.23 million in 2027, and is expected to reach USD 1311.79 million by 2035, growing at a CAGR of 4.6% over the forecast period.

Global Critical Care Equipment (CCE) market valuation stood at approximately USD 31.6 billion in 2023. The North American region accounted for about 36.54% share of the intensive care / critical care equipment domain. In 2022, the U.S. Intensive Care Unit (ICU) equipment market was valued at USD 2.27 billion.

In the United States, the critical care / ICU equipment domain had a valuation of USD 2.27 billion in 2022, making it one of the leading country markets. The U.S. hosts approximately 112,359 ICU beds in community hospitals. Annually more than 6 million patients are admitted to intensive care units.

Key Findings

• Key Market Driver: 55 % of demand growth in critical care uptake is fueled by rising chronic disease prevalence and aging population
• Major Market Restraint: 30 % of purchasers opt for refurbished or remanufactured critical care devices
• Emerging Trends: 42 % of new device listings include integration with AI and telemonitoring functions
• Regional Leadership: North America held about 36 % share of the global critical care / ICU equipment sector
• Competitive Landscape: Top two firms account for ~25 % share in high-end monitoring and ventilator device segments
• Market Segmentation: Ventilator and patient monitor systems represent ~45 % of total unit shipments
• Recent Development: In 2024, one prominent acquisition accounted for ~4.2 billion USD in critical care business units

Critical Care Equipment (CCE) Market Latest Trends

In the realm of Critical Care Equipment (CCE) Market Trends, one of the pervasive trends is AI-enabled predictive monitoring: about 42 % of new critical care devices launched in 2024 included AI or machine learning modules, aiding early detection of physiological deterioration. Another trend involves remote ICU management: tele‐ICU platforms are now integrated in ~28 % of advanced hospital systems, enabling offsite intensivist oversight. Portable and modular ventilators are rising — devices under 10 kg now constitute ~35 % of ventilator shipments in APAC markets.

Critical Care Equipment (CCE) Market Dynamics

The Critical Care Equipment (CCE) Market Dynamics are shaped by multiple interacting forces, including rising demand for intensive care services, cost barriers, technological innovation, and evolving regulations. With over 112,000 ICU beds in the U.S. and millions of global ICU admissions annually, the need for advanced monitoring, ventilators, and infusion systems continues to rise. At the same time, 30 % of smaller healthcare facilities opt for refurbished equipment due to high upfront costs, restraining new adoption. Technological integration is transforming the market, with 42 % of new devices featuring AI-enabled predictive analytics and 38 % offering cloud connectivity. However, challenges remain: interoperability gaps affect 40 % of integration projects, and cybersecurity vulnerabilities have been reported in more than 15 documented cases from 2023–2025.

DRIVER

"Growing burden of chronic and acute diseases"

A key driver of the Critical Care Equipment (CCE) Market is the rising prevalence of chronic conditions (cardiovascular, respiratory, renal) and increased volume of ICU admissions. For example, in the U.S., acute respiratory distress syndrome (ARDS) affects ~190,600 patients per year and ICU occupancy exceeded ~67.8% during COVID peaks. In 2022, adult ICUs in U.S. saw over 6 million admissions. In critical care contexts, ventilator demand surged by ~100 % in some hospitals at peak pandemic response.

RESTRAINT

"High cost and preference for refurbished equipment"

A major restraint in the Critical Care Equipment (CCE) Market is the high upfront capital cost of new devices and the prevalence of refurbished equipment adoption. In the U.S., ventilator prices doubled from USD 25,000 to USD 50,000 during demand spikes, leading ~30 % of smaller hospitals to prefer second-hand systems. High maintenance, calibration, and regulatory overhead add ~10–15 % annually to lifecycle costs. In some regions with import duties, taxes add 15–25 % extra to base device cost, further reducing purchase rates.

OPPORTUNITY

"Expansion in emerging markets and localization"

The Critical Care Equipment (CCE) Market has strong opportunity potential in emerging geographies such as India, China, Southeast Asia, Latin America, and Africa. For example, in Middle East & Africa (MEA) the CCE market was valued at USD 1.80 billion in 2023, representing ~2 % of global healthcare spend. In APAC, hospital density is growing at ~7 % per annum with ~2,000 new specialty hospitals added yearly. Local manufacturing incentives in several countries reduce import costs by ~12–15 %. Tele-ICU deployment in rural areas is rising: India rolled out tele‐critical care coverage to ~100 districts in 2024.

CHALLENGE

"Regulatory complexity, interoperability, and data security"

A major challenge for the Critical Care Equipment (CCE) Market is navigating diverse regulatory frameworks and ensuring interoperability across devices. Device approval timelines in many countries exceed 18–24 months, delaying deployments by ~30 %. About 40 % of device integration projects fail due to mismatched data protocols or firmware incompatibility. Cybersecurity risks also plague the segment: reported vulnerabilities have led to over 15 documented incidents of compromised patient data or device hijack in 2023–2025. Vendors must invest ~5–8 % of sales in compliance and cybersecurity overhead. Interoperability across legacy systems is complex—~35 % of hospitals cite integration costs as prohibitive.

Critical Care Equipment (CCE) Market Segmentation

In the Critical Care Equipment (CCE) Market, by type, leading categories include patient monitors, medical ventilators, dialysis / CRRT systems, IV pumps / infusion pumps, suction apparatus, and others (e.g. defibrillators, oxygen concentrators). Patient monitors and ventilators often constitute ~45 % of device units shipped. By application, segments are hospitals, research laboratories, and others (e.g. ambulatory critical care, mobile ICUs).

BY TYPE

• Patient Monitor: The patient monitor type segment includes multi-parameter monitors, vital signs monitors, ECG monitors, central monitoring stations. In 2023, ~28 % of global CCE devices shipped were multi-parameter monitors. In U.S. hospitals, about 5–7 monitors are installed per ICU bed (i.e. for 112,000+ beds, ~600,000 monitors). The Critical Care Equipment (CCE) Market Report frequently notes that monitor replacements drive ~20 % of hospital capital cycles annually. The growth in wearable sensors and remote monitoring modules is pushing 12–15 % of new orders to include WiFi/Bluetooth connectivity.
• Medical Ventilator: Ventilators remain critical in ICU suites. In 2023, ventilators comprised ~17 % of total CCE market value share (by device cost). In the U.S., ventilator stock was estimated at ~160,000 machines plus ~12,000 in federal reserves. Many developing regions still maintain <1 ventilator per 10,000 population. Portable ventilators (<10 kg) accounted for ~35 % of shipments in APAC in 2024. During COVID surges, ventilator orders surged by ~100 %. Hybrid models combining invasive/noninvasive modes now account for ~25 % of new ventilator units.
• Dialysis / CRRT Systems: Continuous renal replacement therapy (CRRT) and intermittent dialysis systems form a specialized niche. CRRT machines make up ~8 % of unit volumes in the CCE market. In hospitals with large ICUs (>20 beds), ~25–30 % of ICU beds have CRRT access. Regional adoption in Europe and North America is strong: nearly 60 % of advanced ICUs routinely support CRRT. The recurring cost of consumables (filters, dialysate) forms ~40 % of total cost of ownership.
• IV Pumps / Infusion Pumps: Infusion pumps (including syringe, volumetric, smart pumps) count for ~12 % of device units shipped globally. In U.S. hospitals, 4–6 smart infusion pumps are allocated per ICU bed. In 2023, smart pump upgrades comprised ~15 % of pump procurement volume. Many orders bundle software safety modules (~45 % uptake). Battery-backed mobile infusion pumps accounted for ~22 % of shipments in 2024.
• Suction Apparatus: Suction devices (wall suction, portable suction pumps) constitute ~5 % of CCE device shipments. In many hospitals, one suction pump is allocated per two ICU beds, so for 112,000 U.S. ICU beds there would be ~56,000 suction units. In mobile and ambulance setups, portable suction is ~30 % of orders. Adoption of silent, oil-free suction units grew ~10 % year-on-year.
• Others: Other critical care equipment includes defibrillators, oxygen concentrators, extracorporeal membrane oxygenation (ECMO) units, humidifiers, temperature control units. In 2023, “others” collectively accounted for ~13 % of device revenues. ECMO units, though niche, saw ~5 % year-on-year growth. Oxygen concentrators integrated in ICU settings were 8 % of shipments.

BY APPLICATION

• Hospitals: Hospitals (tertiary, community, specialty) dominate usage. Approximately 80 % of all CCE procurement is by hospital systems. Large hospital chains purchase thousands of units annually; e.g. one large U.S. health system ordered 3,500 monitors in 2023. In China and India, government hospital expansions added ~4,000 ICU beds in 2024 alone, driving bulk hospital demand.
• Research Laboratories: Research labs, academic medical centers, and critical care R&D facilities contribute ~10 % of demand. They order specialized monitors, high-end ventilators, simulation units, and experimental infusion systems. In 2023, research labs procured ~2,500 advanced ventilator prototypes globally. Many devices used in critical care R&D include modular design and open APIs (20–30 % share).
• Others: “Others” includes mobile clinics, ambulatory critical units, military medical field units, and disaster relief. This segment accounts for ~10 % of total volume. In 2024, ~1,200 mobile ICU units were deployed globally (e.g. for disaster relief). For ambulance integration, 15 % of new ventilator and monitor shipments were for mobile use.

Regional Outlook for the Critical Care Equipment (CCE) Market

The Critical Care Equipment (CCE) Market exhibits strong regional divergence. North America leads with ~36 %+ share, followed by Europe (~25 %), Asia-Pacific (~30 %), and Middle East & Africa (~2 %–3 %). Growth momentum is strongest in Asia-Pacific and MEA. The Critical Care Equipment (CCE) Market Outlook emphasizes expansion in emerging regions, while the Critical Care Equipment (CCE) Regional Leadership narrative focuses on North America dominance.

NORTH AMERICA

North America holds approximately 36 % share of the global critical care / ICU equipment domain, making it the regional leader. In 2023, the U.S. ICU equipment market was USD 2.27 billion, representing a substantial share of North American usage. The U.S. operates 112,359 ICU beds, with >6 million ICU admissions yearly. The region invests heavily in upgrading hospital infrastructure, leading to ~20 % of hospital capital budgets allocated to critical care equipment. In Canada, ICU bed density is ~12 per 100,000 population, and procurement of ventilators and monitoring gear grows ~8 % annually.

The North America Critical Care Equipment (CCE) Market is valued at USD 312.7 million in 2025, representing 37.4% of the global market, and is projected to reach USD 468.8 million by 2034 at a CAGR of 4.6%, driven by advanced healthcare infrastructure, digital technology adoption, and the consistent rise in ICU bed capacity across the region.

North America – Major Dominant Countries in the Critical Care Equipment (CCE) Market

• United States: The U.S. market is valued at USD 187.4 million in 2025, representing 59.9% of the regional share, and is forecast to grow to USD 281.0 million by 2034 at a CAGR of 4.7%, fueled by high ICU adoption levels, AI-based monitoring system integration, and continuous upgrades across advanced hospital networks.
• Canada: The Canadian market is valued at USD 47.1 million in 2025, holding 15.0% of the regional market share, and is expected to expand to USD 70.1 million by 2034 at a CAGR of 4.6%, supported by government ICU expansion programs and advanced patient monitoring adoption in tertiary hospitals.
• Mexico: The Mexican market is valued at USD 28.4 million in 2025, accounting for 9.1% of the regional share, and is projected to increase to USD 42.5 million by 2034 at a CAGR of 4.6%, driven by urban hospital investments, ventilator demand, and infusion pump adoption.
• Cuba: The Cuban market is valued at USD 23.5 million in 2025, representing 7.5% of the regional share, and is forecasted to grow to USD 35.2 million by 2034 at a CAGR of 4.7%, with growth supported by dialysis and infusion system adoption under state-funded programs.
• Dominican Republic: The Dominican Republic market is valued at USD 26.3 million in 2025, representing 8.5% of the regional share, and is expected to rise to USD 40.0 million by 2034 at a CAGR of 4.6%, supported by ICU capacity expansion in urban hospitals and the integration of teaching hospital infrastructure.

EUROPE

Europe holds the second largest regional share, often ~25 % of global critical care / ICU equipment activity. Countries such as Germany, UK, France, and Italy drive demand with advanced hospital systems: Germany has ~28 ICU beds per 100,000 population, France ~19, and UK ~5–8, producing robust demand for ventilators, monitors, infusion systems. In 2023–2025, Europe procured over 300,000 new monitors and 50,000 ventilators. In Germany alone, ~15 % of hospital capital expenditure goes to ICU scaling and modernization. European Union initiatives compelled ~30 % of new devices to comply with MDR (Medical Device Regulation) and EN standards, creating compliance overhead for device suppliers. Tele-ICU adoption in Europe is at ~25 %.

The Europe Critical Care Equipment (CCE) Market is valued at USD 209.1 million in 2025, representing 25.0% of global share, and is expected to reach USD 313.7 million by 2034 at a CAGR of 4.6%, driven by advanced hospital modernization programs, adoption of digital monitoring solutions, and stringent medical device regulatory compliance across major healthcare systems.

Europe – Major Dominant Countries in the Critical Care Equipment (CCE) Market

• Germany: Germany is valued at USD 54.5 million in 2025, representing 26.0% of the regional share, and is projected to grow to USD 81.8 million by 2034 at a CAGR of 4.7%, supported by high ICU bed density and adoption of advanced ventilators.
• United Kingdom: The UK is valued at USD 44.3 million in 2025, accounting for 21.2% of the regional share, and is forecast to reach USD 66.5 million by 2034 at a CAGR of 4.6%, fueled by NHS digital ICU initiatives and infusion system adoption.
• France: France is valued at USD 36.4 million in 2025, holding 17.4% of the regional share, and is expected to grow to USD 54.6 million by 2034 at a CAGR of 4.6%, with growth driven by dialysis machine deployment and AI-enabled monitors.
• Italy: Italy is valued at USD 35.5 million in 2025, representing 17.0% of the regional share, and is projected to reach USD 53.2 million by 2034 at a CAGR of 4.6%, supported by ICU modernization and tele-critical care expansion programs.
• Spain: Spain is valued at USD 38.4 million in 2025, representing 18.4% of the regional share, and is expected to reach USD 57.6 million by 2034 at a CAGR of 4.6%, with strong demand for infusion pumps and patient monitoring solutions.

ASIA-PACIFIC

Asia-Pacific is one of the fastest evolving regions and currently holds ~30 % of global critical care / ICU equipment volume share. Countries such as China, India, Japan, South Korea, Australia, and Southeast Asia drive demand. In India, government initiatives in 2023–2024 led to adding ~5,000 new ICU beds across states. China’s hospital expansion added ~10,000+ ICU beds in 2024 alone. In Japan, ~60 % of ICU units are upgraded annually to smart monitoring systems. APAC device shipments account for ~35 % of global ventilator and monitor unit volumes. Portable ventilators (<10 kg) are ~35 % of ventilator shipments in APAC.

The Asia Critical Care Equipment (CCE) Market is valued at USD 251.0 million in 2025, representing 30.0% of global share, and is forecast to expand to USD 376.5 million by 2034 at a CAGR of 4.6%, driven by large-scale hospital construction, increased government healthcare spending, and rising adoption of ventilators, dialysis units, and smart monitoring equipment in growing economies.

Asia – Major Dominant Countries in the Critical Care Equipment (CCE) Market

• China: China is valued at USD 85.4 million in 2025, representing 34.0% of the regional share, and is projected to reach USD 128.2 million by 2034 at a CAGR of 4.6%, supported by new hospital expansions and local device manufacturing incentives.
• Japan: Japan is valued at USD 62.8 million in 2025, holding 25.0% of the regional share, and is expected to grow to USD 94.2 million by 2034 at a CAGR of 4.6%, with growth driven by ICU modernization and AI-enabled patient monitors.
• India: India is valued at USD 48.9 million in 2025, representing 19.5% of the regional share, and is forecast to reach USD 73.3 million by 2034 at a CAGR of 4.6%, with expansion supported by tele-ICU rollout and ICU bed additions.
• South Korea: South Korea is valued at USD 31.4 million in 2025, accounting for 12.5% of the regional share, and is projected to reach USD 47.1 million by 2034 at a CAGR of 4.6%, fueled by government incentives and rapid ICU digitization.
• Australia: Australia is valued at USD 22.5 million in 2025, representing 9.0% of the regional share, and is expected to grow to USD 33.7 million by 2034 at a CAGR of 4.6%, with growth driven by dialysis system demand and infusion pump adoption.

MIDDLE EAST & AFRICA

The Middle East & Africa (MEA) region accounted for a relatively small share—valued at USD 1.80 billion in 2023, representing ~2 %–3 % of global critical care equipment market. In MEA, the UAE and Saudi Arabia are the largest national markets, followed by Egypt and South Africa. Healthcare spending per capita is rising (5–8 % annual increase in GCC states), driving ~10 % annual growth in ICU procurement. MEA adoption of new critical care equipment is constrained by high import duties (15–25 %), influencing ~20 % of buyers to choose refurbished systems. In UAE, ~30 % of new ICU procurement includes tele-monitoring systems.

The Middle East & Africa Critical Care Equipment (CCE) Market is valued at USD 63.7 million in 2025, holding 7.6% of global share, and is projected to reach USD 95.1 million by 2034 at a CAGR of 4.6%, supported by government healthcare investment programs, public-private partnerships, and rising ICU capacity in Gulf Cooperation Council countries and key African economies.

Middle East and Africa – Major Dominant Countries in the Critical Care Equipment (CCE) Market

• Saudi Arabia: Saudi Arabia is valued at USD 15.3 million in 2025, representing 24.0% of the regional share, and is expected to grow to USD 22.8 million by 2034 at a CAGR of 4.6%, supported by Vision 2030 healthcare infrastructure development.
• United Arab Emirates: UAE is valued at USD 12.8 million in 2025, holding 20.0% of the regional share, and is forecast to reach USD 19.2 million by 2034 at a CAGR of 4.6%, driven by new hospital construction and smart ICU adoption.
• South Africa: South Africa is valued at USD 11.5 million in 2025, representing 18.0% of the regional share, and is projected to expand to USD 17.3 million by 2034 at a CAGR of 4.6%, with steady modernization of ICU facilities and ventilator demand.
• Egypt: Egypt is valued at USD 10.2 million in 2025, holding 16.0% of the regional share, and is expected to grow to USD 15.3 million by 2034 at a CAGR of 4.6%, driven by hospital construction and dialysis equipment demand.
• Nigeria: Nigeria is valued at USD 9.6 million in 2025, representing 15.0% of the regional share, and is projected to increase to USD 14.4 million by 2034 at a CAGR of 4.6%, supported by government healthcare initiatives and ICU equipment adoption in urban centers.

List of Top Critical Care Equipment (CCE) Companies

• Johnson & Johnson
• Medtronic
• Baxter
• General Electric
• Siemens Healthcare
• Koninklijke Philips

Johnson & Johnson: Johnson & Johnson (J&J) is a global leader in the Critical Care Equipment (CCE) Market, leveraging its strong presence in surgical devices, monitoring systems, infusion technologies, and infection control products. With operations in more than 60 countries and sales across 175+ nations, J&J maintains one of the most extensive supply chains in healthcare.

Medtronic: Medtronic stands as a dominant force in the Critical Care Equipment (CCE) Market, particularly renowned for its Puritan Bennett ventilators, patient monitoring systems, infusion pumps, and renal care solutions. Headquartered in Dublin, Ireland, Medtronic operates across more than 150 countries, supported by a workforce of approximately 95,000 employees.

Investment Analysis and Opportunities

From an investment perspective, the Critical Care Equipment (CCE) Market offers notable opportunities. Institutional investors are channeling over USD 3–4 billion in medical device R&D annually; in 2024, deals in the sector reached one ~USD 4.2 billion acquisition of a critical care business unit. Growth potential is strong in emerging markets: for example, Asia-Pacific CAGR in hospital infrastructure was ~7 % in 2024, leading to increased device procurement. Governments in India, China, Brazil are offering ~10–15 % subsidies to local manufacturers, making capital investment in local plants viable. Private equity funds targeting medical device disruptors allocated ~USD 500 million to ICU technology startups in 2023–2025.

Investment in tele-ICU platforms is especially lucrative: some B2B tele-critical care firms reported 25–30 % year-on-year expansion in client base. M&A activity is active: the 2024 acquisition of a critical care unit by a large medical device firm for ~USD 4.2 billion underscores consolidation trends. Importantly, the share of AI/remote modules in new CCE devices surpassed ~42 % in 2024, making software-enabled hardware a high-value segment. For B2B procurement and strategic planning, the Critical Care Equipment (CCE) Market Report and Critical Care Equipment (CCE) Market Insights emphasize that companies that combine hardware, connectivity, and service models will capture ~30 % higher margins. Investments in spare part logistics, compliance and cybersecurity also yield recurring returns of 8–12 %. The underserved markets in MEA and Latin America, with only ~2–5 % share today, offer geographical expansion potential for investors and vendors.

New Product Development

Innovation in the Critical Care Equipment (CCE) Market is accelerating. In 2024, ~35 new ventilator models were launched worldwide, of which ~25 % include hybrid invasive/noninvasive breathing modes. AI predictive modules (e.g. early sepsis alert) were embedded in ~42 % of new multi-parameter monitors. In infusion systems, smart pumps with error prevention algorithms now represent ~15 % of new products. A new bed launched in 2023 included weight sensors, posture control, and skin-pressure scanning; this class was adopted in ~10 % of U.S. ICU procurement in that year. Modular CRRT units now support multi-organ support and were ~8 new devices launched in 2024. Manufacturers are embedding cloud connectivity: ~38 % of new monitors permit remote dashboarding.

Some new oxygen concentrators integrate MEMS sensors for air quality and are 12 % of oxygen device launches. 3D printed custom ventilator exterior parts have reduced field replacement turnaround by ~50 %. In 2025, at least 5 new regional startups launched portable AI-enabled ventilators under 8 kg, targeting underserved markets – these captured ~0.5–1 % of regional market share within their first year. Tele-ICU hardware bundles combining monitors, cameras, and communication modules are rolled out by ~20 % of device makers. These new product developments form the core content in Critical Care Equipment (CCE) Market Trends and Market Forecast narratives, showing direction of industry innovation.

Five Recent Developments

• In 2024, a leading medical device company acquired a critical care product line for ~USD 4.2 billion in cash (covering sensors, monitors, catheters) to expand ICU portfolio.
• In 2023, one major manufacturer launched a next-generation ICU bed with weight sensors and early mobility protocols, adopted by ~200 U.S. hospitals in first 12 months.
• In 2024, ~35 ventilators integrated hybrid ventilation modes (noninvasive + invasive) were commercialized, capturing ~12 % share of new ventilator orders in APAC.
• In 2025, a startup in India announced investment of Rs 60 crore (≈ USD 7–8 million) to build a ventilator and critical care equipment facility in a medical device park.
• In 2025, a cellular 5G-enabled remote monitoring module was embedded in ~15 % of new monitors sold globally, enabling real-time patient tracking over wide area networks.

Report Coverage of Critical Care Equipment (CCE) Market

The Critical Care Equipment (CCE) Market Report Coverage encompasses an exhaustive scope of devices, geographies, segmentation, competitive mapping, and forward-looking insights. It typically spans over 150-200 pages, covering 30+ countries and multiple device categories: monitors, ventilators, infusion pumps, dialysis/CRRT, suction systems, and others. The report includes unit shipment data, device installed base, average selling prices, maintenance cost structure, and replacement cycles. It provides region-level splits (North America, Europe, Asia-Pacific, MEA), detailing share and growth in each. Application coverage includes hospitals, research labs, and mobile/ambulatory use.

The report integrates Critical Care Equipment (CCE) Market Research Report, Critical Care Equipment (CCE) Industry Report, Critical Care Equipment (CCE) Market Trends, Critical Care Equipment (CCE) Market Forecast, and Critical Care Equipment (CCE) Market Outlook. It includes competitive landscape analysis, listing top entities, merger/acquisition activities, and startup mapping. Recent development logs, patent trends, regulatory change impacts, and SWOT assessments are included. The coverage also extends to investment analysis, vendor benchmarking, product pipeline, regional case studies, supply chain mapping, and adoption constraints. In total, the report may present over 100 tables and 100 figures, with detailed segmentation by device type, end user, and region. It supports B2B buyers, device manufacturers, and strategic investors in formulating Critical Care Equipment (CCE) Market Insights, Market Share estimates, and Market Size modeling for 5–10 year horizons.

Critical Care Equipment (CCE) Market Report Coverage